Bromocriptine Mesylate
NDC 70954-951, Bromocriptine Mesylate, capsule, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-951
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA017962
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-951 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BROMOCRIPTINE MESYLATE5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-951-10 | 70954095110 | 30 CAPSULE in 1 BOTTLE (70954-951-10) |
| 70954-951-20 | 70954095120 | 100 CAPSULE in 1 BOTTLE (70954-951-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/17f3a343-1782-4799-95ba-31dfe93be2cf
Use it
Look up 70954-951 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-951 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-951. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.